Patents by Inventor Matthew Kalnik

Matthew Kalnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8232072
    Abstract: Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies. Related methods are also described.
    Type: Grant
    Filed: June 9, 2009
    Date of Patent: July 31, 2012
    Assignee: Nabi Biopharmaceuticals
    Inventors: Matthew Kalnik, Matthew Hohenboken, Paul Kessler, Ali Fattom, Raafat Fahim, Leslie Hudson
  • Publication number: 20110182918
    Abstract: Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies, and personalized drug treatment methods, including methods and kits for the treatment and prevention of drug addiction, drug use and drug abuse, which include determining the subject's pre-vaccine levels of antibodies specific for the drug hapten at issue. Related methods are also described.
    Type: Application
    Filed: December 16, 2010
    Publication date: July 28, 2011
    Inventors: Matthew Kalnik, Matthew Hohenboken, Paul Kessler, Ali Fattom, Raafat Fahim, Leslie Hudson
  • Publication number: 20110064750
    Abstract: Described are methods and kits related to treating nicotine addiction and increasing the likelihood of nicotine abstinence. Methods and kits for reestablishing nicotine abstinence after a relapse to nicotine use are also described.
    Type: Application
    Filed: July 29, 2010
    Publication date: March 17, 2011
    Inventors: Raafat Fahim, Ali Fattom, Paul Kessler, Matthew Kalnik
  • Publication number: 20100040638
    Abstract: Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies. Related methods are also described.
    Type: Application
    Filed: June 9, 2009
    Publication date: February 18, 2010
    Inventors: Matthew KALNIK, Mathew Hohenboken, Paul Kessler, Ali Fattom, Raafat Fahim, Leslie Hudson